197:
534:
527:
520:
232:
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
419:
582:
693:
440:
415:
201:
688:
678:
395:
377:
609:
315:
660:
205:
740:
573:
283:
259:
444:
75:
665:
54:
139:
44:
30:
226:) can be created by placing the letter Q in front of the human ATC code: for example,
734:
683:
634:
593:
588:
466:
371:
346:
289:
265:
238:
91:
502:
629:
624:
578:
568:
512:
358:
327:
323:
271:
255:
71:
60:
50:
40:
649:
639:
352:
340:
223:
488:
219:
209:
179:
174:
169:
164:
159:
154:
149:
144:
134:
129:
124:
119:
114:
109:
64:
22:
208:
and other medical products. Subgroup B06 is part of the anatomical group
703:
698:
644:
563:
469:. WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018
389:
383:
334:
79:
416:"ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis"
598:
277:
247:
719:
307:
26:
298:
516:
505:. WHO Collaborating Centre for Drug Statistics Methodology.
491:. WHO Collaborating Centre for Drug Statistics Methodology.
445:"Anatomical Therapeutic Chemical (ATC) Classification"
198:
712:
658:
607:
552:
200:, a system of alphanumeric codes developed by the
528:
8:
535:
521:
513:
18:
407:
100:
21:
7:
16:Pharmaceutical drug classification
14:
196:is a therapeutic subgroup of the
365:B06AX Other hematological agents
204:(WHO) for the classification of
503:"ATCvet Index 2022: code QB06"
489:"ATC/DDD Index 2022: code B06"
212:Blood and blood forming organs
1:
420:National Institutes of Health
543:Other hematological agents (
447:. World Health Organization
757:
694:Lovotibeglogene autotemcel
467:"Structure and principles"
194:Other hematological agents
441:World Health Organization
202:World Health Organization
689:Exagamglogene autotemcel
679:Betibeglogene autotemcel
396:Exagamglogene autotemcel
378:Betibeglogene autotemcel
316:hereditary angioedema
45:Antithrombotic agents
314:B06AC Drugs used in
191:ATC code B06
31:blood forming organs
661:sickle cell disease
583:+desoxyribonuclease
574:Desoxyribonuclease
284:Desoxyribonuclease
260:desoxyribonuclease
728:
727:
188:
187:
76:Blood substitutes
748:
666:beta thalassemia
537:
530:
523:
514:
507:
506:
499:
493:
492:
485:
479:
478:
476:
474:
463:
457:
456:
454:
452:
437:
431:
430:
428:
426:
412:
55:Antihemorrhagics
19:
756:
755:
751:
750:
749:
747:
746:
745:
731:
730:
729:
724:
708:
663:
654:
611:
603:
548:
541:
511:
510:
501:
500:
496:
487:
486:
482:
472:
470:
465:
464:
460:
450:
448:
439:
438:
434:
424:
422:
414:
413:
409:
404:
367:
319:
303:
251:
243:
233:
231:
184:
101:Other ATC codes
17:
12:
11:
5:
754:
752:
744:
743:
733:
732:
726:
725:
723:
722:
716:
714:
710:
709:
707:
706:
701:
696:
691:
686:
681:
675:
673:
659:Drugs used in
656:
655:
653:
652:
647:
642:
637:
632:
627:
621:
619:
608:Drugs used in
605:
604:
602:
601:
596:
591:
586:
576:
571:
566:
560:
558:
550:
549:
542:
540:
539:
532:
525:
517:
509:
508:
494:
480:
458:
432:
406:
405:
403:
400:
399:
398:
392:
386:
380:
374:
366:
363:
362:
361:
355:
349:
343:
337:
331:
318:
312:
311:
310:
302:
295:
294:
293:
292:, combinations
286:
280:
274:
268:
262:
250:
244:
242:
235:
186:
185:
183:
182:
177:
172:
167:
162:
157:
152:
147:
142:
137:
132:
127:
122:
117:
112:
106:
103:
102:
98:
97:
96:
95:
83:
68:
57:
47:
34:
33:
15:
13:
10:
9:
6:
4:
3:
2:
753:
742:
739:
738:
736:
721:
718:
717:
715:
711:
705:
702:
700:
697:
695:
692:
690:
687:
685:
684:Crizanlizumab
682:
680:
677:
676:
674:
671:
667:
662:
657:
651:
648:
646:
643:
641:
638:
636:
635:Conestat alfa
633:
631:
628:
626:
623:
622:
620:
617:
613:
606:
600:
597:
595:
594:Streptokinase
592:
590:
589:Hyaluronidase
587:
584:
580:
577:
575:
572:
570:
567:
565:
562:
561:
559:
556:
551:
546:
538:
533:
531:
526:
524:
519:
518:
515:
504:
498:
495:
490:
484:
481:
468:
462:
459:
446:
442:
436:
433:
421:
417:
411:
408:
401:
397:
393:
391:
387:
385:
381:
379:
375:
373:
372:Crizanlizumab
369:
368:
364:
360:
356:
354:
350:
348:
347:Conestat alfa
344:
342:
338:
336:
332:
329:
325:
321:
320:
317:
313:
309:
305:
304:
300:
296:
291:
290:Streptokinase
287:
285:
281:
279:
275:
273:
269:
267:
266:Hyaluronidase
263:
261:
257:
253:
252:
249:
245:
240:
239:hematological
236:
234:
229:
225:
221:
216:
214:
213:
207:
203:
199:
195:
192:
181:
178:
176:
173:
171:
168:
166:
163:
161:
158:
156:
153:
151:
148:
146:
143:
141:
138:
136:
133:
131:
128:
126:
123:
121:
118:
116:
113:
111:
108:
107:
105:
104:
99:
93:
92:hematological
89:
88:
84:
81:
77:
74:
73:
69:
66:
63:
62:
58:
56:
53:
52:
48:
46:
43:
42:
38:
37:
36:
35:
32:
28:
24:
20:
669:
630:C1-inhibitor
625:Berotralstat
615:
579:Fibrinolysin
569:Chymotrypsin
554:
544:
497:
483:
471:. Retrieved
461:
449:. Retrieved
435:
423:. Retrieved
410:
359:Berotralstat
324:C1-inhibitor
272:Chymotrypsin
256:Fibrinolysin
227:
224:ATCvet codes
217:
211:
193:
190:
189:
86:
85:
70:
67:preparations
59:
49:
39:
650:Lanadelumab
640:Ecallantide
353:Lanadelumab
341:Ecallantide
237:B06A Other
612:angioedema
610:hereditary
425:1 February
402:References
220:veterinary
218:Codes for
65:Antianemic
23:ATC code B
741:ATC codes
704:Voxelotor
699:Mitapivat
645:Icatibant
564:Bromelain
553:Enzymes (
473:3 January
451:3 January
390:Mitapivat
384:Voxelotor
335:Icatibant
82:solutions
80:perfusion
735:Category
394:B06AX05
388:B06AX04
382:B06AX03
376:B06AX02
370:B06AX01
357:B06AC06
351:B06AC05
345:B06AC04
339:B06AC03
333:B06AC02
322:B06AC01
306:B06AB01
301:products
288:B06AA55
282:B06AA10
276:B06AA07
270:B06AA04
264:B06AA03
254:B06AA02
599:Trypsin
330:derived
278:Trypsin
248:Enzymes
713:Others
328:plasma
297:B06AB
246:B06AA
241:agents
230:.
94:agents
90:Other
720:Hemin
670:B06AX
616:B06AC
555:B06AA
308:Hemin
222:use (
206:drugs
27:Blood
664:and
475:2022
453:2022
427:2020
299:Heme
258:and
228:QB06
78:and
29:and
545:B06
87:B06
72:B05
61:B03
51:B02
41:B01
737::
443:.
418:.
326:,
215:.
210:B
140:QI
25::
672:)
668:(
618:)
614:(
585:)
581:(
557:)
547:)
536:e
529:t
522:v
477:.
455:.
429:.
180:V
175:S
170:R
165:P
160:N
155:M
150:L
145:J
135:H
130:G
125:D
120:C
115:B
110:A
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.